Humanization of antibodies

被引:158
作者
Almagro, Juan C. [1 ]
Fransson, Johan [2 ]
机构
[1] Centocor Inc, R&D, Radnor, PA 19087 USA
[2] Centocor Discovery Res, San Diego, CA 92121 USA
来源
FRONTIERS IN BIOSCIENCE-LANDMARK | 2008年 / 13卷
关键词
immunoglobulins; Igs; hypervariable loops; framework; FR; complementarity determining regions; CDR; SRD; canonical structures; CDR grafting; SDR grafting Resurfacing; Superhumanization; Guided Selection; Humaneering; Framework Shuffling; review;
D O I
10.2741/2786
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Humanization has played a fundamental role in the remarkable progress of antibodies as therapeutic reagents. Here we have reviewed the publications on antibody humanization since the first report on CDR grafting in the second half of the 1980's up to June 2007. We describe the two main trends in the field: rational and empirical methods to humanize antibodies. Rational methods rely on the so-called design cycle. It consists of generating a small set of variants, which are designed based on the antibody structure and/or sequence information, and assessing their binding or any other characteristic of interest. Rational methods include CDR grafting, Resurfacing, Superhumanization and Human String Content Optimization. In contrast to rational methods, empirical methods are based on generating large combinatorial libraries and selecting the desired variants by enrichment technologies such as phage, ribosome or yeast display, or by high throughput screening techniques. The latter methods rest on selection rather than making assumptions on the impact of mutations on the antibody structure. These methods include Framework Libraries, Guided Selection, Framework Shuffling and Humaneering.
引用
收藏
页码:1619 / 1633
页数:15
相关论文
共 109 条
[31]   Rational humanization of the powerful antithrombotic anti-GPIbα antibody:: 6B4 [J].
Fontayne, Alexandre ;
Vanhoorelbeke, Karen ;
Pareyn, Inge ;
Van Rompaey, Isabel ;
Meiring, Muriel ;
Lamprecht, Seb ;
Roodt, Jan ;
Desmet, Johan ;
Deckmyn, Hans .
THROMBOSIS AND HAEMOSTASIS, 2006, 96 (05) :671-684
[32]   ANTIBODY FRAMEWORK RESIDUES AFFECTING THE CONFORMATION OF THE HYPERVARIABLE LOOPS [J].
FOOTE, J ;
WINTER, G .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 224 (02) :487-499
[33]   Structure-function studies of two synthetic anti-vascular endothelial growth factor Fabs and comparison with the AVASTIN™ Fab [J].
Fuh, G ;
Wu, P ;
Liang, WC ;
Ultsch, M ;
Lee, CV ;
Moffat, B ;
Wiesmann, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (10) :6625-6631
[34]   SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity [J].
Gonzales, NR ;
Padlan, EA ;
De Pascalis, R ;
Schuck, P ;
Schlom, J ;
Kashmiri, SVS .
MOLECULAR IMMUNOLOGY, 2004, 41 (09) :863-872
[35]   RESHAPING A THERAPEUTIC CD4 ANTIBODY [J].
GORMAN, SD ;
CLARK, MR ;
ROUTLEDGE, EG ;
COBBOLD, SP ;
WALDMANN, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) :4181-4185
[36]  
GRAZIANO RF, 1995, J IMMUNOL, V155, P4996
[37]   ISOLATION OF HIGH-AFFINITY HUMAN-ANTIBODIES DIRECTLY FROM LARGE SYNTHETIC REPERTOIRES [J].
GRIFFITHS, AD ;
WILLIAMS, SC ;
HARTLEY, O ;
TOMLINSON, IM ;
WATERHOUSE, P ;
CROSBY, WL ;
KONTERMANN, RE ;
JONES, PT ;
LOW, NM ;
ALLISON, TJ ;
PROSPERO, TD ;
HOOGENBOOM, HR ;
NISSIM, A ;
COX, JPL ;
HARRISON, JL ;
ZACCOLO, M ;
GHERARDI, E ;
WINTER, G .
EMBO JOURNAL, 1994, 13 (14) :3245-3260
[38]   SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling [J].
Guex, N ;
Peitsch, MC .
ELECTROPHORESIS, 1997, 18 (15) :2714-2723
[39]   A humanized antibody against human cytomegalovirus (CMV) gpUL75 (gH) for prophylaxis or treatment of CMV infections [J].
Hamilton, AA ;
Manuel, DM ;
Grundy, JE ;
Turner, AJ ;
King, SI ;
Adair, JR ;
White, P ;
Carr, FJ ;
Harris, WJ .
JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (01) :59-68
[40]   THE 3-DIMENSIONAL STRUCTURE OF AN INTACT MONOCLONAL-ANTIBODY FOR CANINE LYMPHOMA [J].
HARRIS, LJ ;
LARSON, SB ;
HASEL, KW ;
DAY, J ;
GREENWOOD, A ;
MCPHERSON, A .
NATURE, 1992, 360 (6402) :369-372